Literature DB >> 19496497

Clinical characteristics and surgical outcomes of pediatric retinal detachments with lens disorders.

Nan-Kai Wang1, Tun-Lu Chen, Chi-Chun Lai, Ya-Hui Kuo, An-Ning Chao, Wei-Chi Wu, Kuan-Jen Chen, Yih-Shiou Hwang, Yen-Po Chen, Laura Liu.   

Abstract

PURPOSE: To describe the clinical characteristics and outcomes of eyes with retinal detachments with lens disorders and compare them to eyes with retinal detachments without lens disorders.
METHODS: A retrospective chart review of 42 eyes of 37 children who had retinal detachments with lens disorders was performed. Eyes were compared based on epidemiological data, characteristics of retinal detachment, and anatomical and functional surgical outcomes and were then compared to 254 eyes with retinal detachment without lens disorders.
RESULTS: In eyes with lens disorders, the retina was reattached after the first operation in 13 (31%) eyes and at the end of the intervention in 22 (52%) eyes. Surgical and visual outcomes appeared to be slightly better in the subluxation and dislocation group compared with cataract and aphakia or pseudophakia groups. In eyes without lens disorders, the retina was reattached in 202 (80%) eyes after the first intervention and in 228 (90%) eyes at the end of the intervention.
CONCLUSION: Pediatric retinal detachment with a lens disorder is associated with unsatisfactory surgical and visual outcomes compared to those without lens disorders. Primary internal and external approaches are suggested in children with complicated retinal detachment with lens disorders.

Entities:  

Mesh:

Year:  2009        PMID: 19496497     DOI: 10.3928/01913913-20090505-07

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  1 in total

1.  Clinical characteristics and surgical outcomes of pediatric rhegmatogenous retinal detachment.

Authors:  Bulent Gurler; Erol Coskun; Veysi Öner; Aysegul Comez; Ibrahim Erbagci
Journal:  Int Ophthalmol       Date:  2015-12-01       Impact factor: 2.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.